Europe Tuberculin Market

Europe Tuberculin Market Size

The tuberculin market size in Europe was valued at USD 60.3 million in 2024. The European market is anticipated to be worth USD 63.5 million in 2025 to USD 95.9 million in 2033, growing at a CAGR of 5.28% during the forecast period.

MARKET DRIVERS

The tuberculin market growth in the European region is majorly driven by an increase in the incidence of tuberculosis, increasing awareness, and growing research and development activities. Also, the high prevalence of diseases and prominent diagnostic rates in Europe are contributing to the market growth in this region. In addition, increasing investments and funding by the government and private sector to develop healthcare infrastructure is augmenting the regional market growth. Furthermore, technological advancements in the healthcare sector provide lucrative growth opportunities for the market players. 

Moreover, initiatives taken by the government to create several healthcare awareness campaigns across Europe are influencing the market expansion. There has been a higher demand for tuberculosis detection in developed countries such as the UK, Germany, and Spain. In addition, animal health has risen to the top of priority lists with human health. As public knowledge of animal health grows, so does the animal health care infrastructure; both of these factors contribute significantly to expanding the European tuberculin market. Additionally, the global COVID-19 pandemic has had a significant impact on the world economy and public health. This particular pandemic has caused severe economic destruction, and not a single country has been left unaffected. In addition, the virus has forced businesses around the globe to change the way they operate. 

MARKET RESTRAINTS

However, apart from the benefits of tuberculin, there are certain drawbacks to be aware of. First, the tuberculin market is held back by anaphylactic and foreign-body responses, including swelling, itching, and other allergic reactions.

REPORT COVERAGE

SEGMENT ANALYSIS

By Product Type Insights

REGIONAL ANALYSIS

Geographically, the U.K. market is one of the prime markets for the tuberculin industry in Europe. Europe is anticipated to witness a rapid share in the Tuberculin Market during the forecast period. Due to greater awareness of TB patients and the adoption of updated methods, tuberculin demand is projected to expand at a high CAGR in Europe. Furthermore, the growing cow population is contributing significantly to the expansion of the tuberculin industry. The presence of major growth contributors such as Germany, the UK, France, Spain, and Italy are significantly contributing to the market share and expanding the regional market growth.  

The European tuberculin market is anticipated to contribute prominently to the global market. An additional cause expected to increase the development of the tuberculin industry is the increasing cattle population in developing countries. Emerging economies like Germany and the United Kingdom are majorly driving the European tuberculin market. Both of these nations are making significant expenditures in the development of healthcare facilities, which has given the tuberculin market in the area a significant boost. The UK is most likely to witness significant share and expand the regional market growth. Due to the growing investments, more leading companies in the tuberculin market are trying to establish their operations in the region. The market is expected to grow steadily in the next years due to high healthcare infrastructure and more awareness campaigns.

KEY MARKET PLAYERS

A few of the promising companies operating in the European Tuberculin market profiled in this report are San Road Biological, Japan BCG, Par Sterile, Sanofi Pasteur, Zoetis, SSI, Thermo Fisher, CNBG, CZ Veterinaria.

MARKET SEGMENTATION

This research report on the Europe tuberculin market is segmented and sub-segmented into the following categories.

By Product Type

• PPD-S
• PPD RT23

By Application

• Human Use
• Animal Use

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe